Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aveo Pharmaceuticals (NQ: AVEO )

6.646 USD -0.024 (-0.36%)
Streaming Delayed Price Updated: 10:39 AM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aveo Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
First Week of AVEO June 18th Options Trading
Investors in AVEO Pharmaceuticals Inc (AVEO) saw new options become available this week, for the June 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AVEO... 
Tags Stocks
From Market News Video
AVEO Announces Appointment of Kevin Cullen, M.D., to Its Board of Directors
AVEO Oncology (Nasdaq: AVEO), a commercial and clinical development stage biopharmaceutical company, today announced the appointment of Kevin J. Cullen, M.D., to the Company’s Board of Directors. A... 
From Business Wire News Releases
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
A slew of drugs, including four new molecular entities, were approved in the month of March. NMEs are drugs that contain active moieties ... 
Tags SUPN Biotech PLX
From Benzinga
Thinking about buying stock in Super League Gaming, Welbilt, Oramed Pharmaceuticals, AVEO Pharmaceuticals, or Oncolytics Biotech?
InvestorsObserver issues critical PriceWatch Alerts for SLGG, WBT, ORMP, AVEO, and ONCY. 
From PR Newswire
AVEO Oncology Announces Addition of FOTIVDA® (tivozanib) into National Comprehensive Cancer Network Clinical Practice Guidelines
AVEO Oncology (Nasdaq: AVEO) today announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include FOTIVDA® (tivozanib) as a recommended regimen... 
From Business Wire News Releases
AVEO Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
AVEO Oncology (Nasdaq: AVEO) today announced the closing of its previously announced underwritten public offering of 6,900,000 shares of its common stock, which includes the full exercise by the... 
From Business Wire News Releases
How The Parts Add Up: IWO Targets $355
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
60 Biggest Movers From Yesterday
Gainers Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares jumped 236.3% to close at $18.33 on Tuesday after the company said it ... 
Tags ANIX EXPR RAIL
From Benzinga
AVEO Announces Pricing of $48.0 Million Public Offering of Common Stock
AVEO Oncology (Nasdaq: AVEO) today announced that it has priced its previously announced underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $8.00 per... 
From Business Wire News Releases
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares climbed 152.3% to $13.75 after the company said it formed a new ... 
Tags MYSZ LPTX WIMI
From Benzinga
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) rose 86.2% to $5.94 in pre-market trading. The surge follows Morgan Stanley ... 
Tags Top Gainers ORMP BLFS
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers BioLife Solutions (NASDAQ:BLFS) shares moved upwards by 11.48% to $43.0 during Monday's after-market session. Today's trading ... 
Tags CMRX CHMA Market News
From Benzinga
8 Stocks Moving In Monday's After-Hours Session
Gainers BioLife Solutions (NASDAQ: BLFS) shares are trading higher after the company reported better-than-expected Q4 EPS and ... 
Tags VIAC Penny Stocks BLFS
From Benzinga
AVEO Announces Proposed Public Offering of Common Stock
AVEO Oncology (Nasdaq: AVEO) today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. In connection with the offering, AVEO intends to grant the... 
From Business Wire News Releases
AVEO Oncology Announces U.S. Commercial Availability of FOTIVDA® (tivozanib) for the Treatment of Adult Patients With Relapsed or Refractory Advanced Renal Cell Carcinoma Ahead of Previous Guidance
AVEO Oncology (Nasdaq: AVEO) today announced that FOTIVDA® (tivozanib) is now commercially available in the United States (U.S.) ahead of the previous March 31, 2021 guidance. On March 10, 2021, the... 
From Business Wire News Releases
First Week of AVEO May 21st Options Trading
Investors in AVEO Pharmaceuticals Inc (AVEO) saw new options begin trading this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AVEO... 
Tags Stocks
From Market News Video
AVEO Oncology Reports Full Year 2020 Financial Results and Provides Business Update
AVEO Oncology (Nasdaq: AVEO) today reported financial results for the full year ended December 31, 2020 and provided a business update. 
From Business Wire News Releases
AVEO Pharmaceuticals, CANbridge AV-203 Licensing Deal Axed, AVEO Regains Ex-North American Rights
AVEO Pharmaceuticals Inc’s(NASDAQ:AVEO) briefpositive news of getting FDA approvalfor Tivozanib in ... 
Tags FDA Small Cap Market News
From Benzinga
AVEO Oncology to Regain Ex-North American Rights to AV-203
AVEO Oncology (Nasdaq: AVEO) today announced that it will regain its rights to AV-203 outside of North America, its clinical-stage potent humanized IgG1 monoclonal antibody that targets ErbB3 (also... 
From Business Wire News Releases
Aveo Pharma's Tivozanib To Be Tested In Combination With Opdivo In Kidney Cancer
AVEO Pharmaceuticals Inc(NASDAQ:AVEO) hasentered into a collaboration and supply ... 
Tags Biotech AVEO Phase 3 Trial
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Offerings SLGL ENTX
From Benzinga
AVEO Oncology Announces Collaboration with Bristol Myers Squibb to Evaluate FOTIVDA® (tivozanib) in Combination with OPDIVO® (nivolumab) in Pivotal Phase 3 TiNivo-2 Trial in IO Relapsed Renal Cell Car
AVEO Oncology (Nasdaq: AVEO) today announced that it has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate FOTIVDA® (tivozanib) in combination with... 
From Business Wire News Releases
76 Biggest Movers From Yesterday
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares climbed 152.5% to close at $4.04 on Thursday after the company disclosed positive ... 
Tags RSI NVFY HGSH
From Benzinga
Are These The Top Health Care Stocks To Buy In Right Now?
Tags Market News
From StockMarket.com
AVEO Oncology Announces Drawdown of $20 Million Tranche Under Hercules Debt Facility
AVEO Oncology (Nasdaq: AVEO) today announced that it has completed a drawdown of $20 million under its previously announced $45 million loan and security agreement with Hercules Capital, Inc. (NYSE:... 
From Business Wire News Releases
Thinking About Buying CPNG Stock, MDMP Stock Or AVEO Stock?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the ... 
Tags CPNG Market News Small Cap
From Benzinga
60 Stocks Moving In Thursday's Mid-Day Session
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 284% to $6.15 after the company disclosed positive topline EB613 Phase 2 ... 
Tags SVRA PDSB LOV
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Entera Bio (NASDAQ:ENTX) stock rose 252.49% to $5.64 during Thursday's regular session. Entera Bio's ... 
Tags INVO IMAC AEZS
From Benzinga
Aveo Pharmaceuticals Stock Volatile After FDA Approval: Technical Levels To Watch
Aveo Pharmaceuticals Inc. (NASDAQ: AVEO) shares are trading higher Thursday after the company received FDA approval for Fotivda for the ... 
Tags Movers Biotech AVEO
From Benzinga
AVEO Crosses Above Average Analyst Target
In recent trading, shares of AVEO Pharmaceuticals Inc (AVEO) have crossed above the average analyst 12-month target price of $10.33, changing hands for $15.28/share. When a stock reaches the target an... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.